Top LARVOL CLIN Alternatives

Koneksa has emerged as a leading digital biomarker company, serving the pharmaceutical and biotechnology industries with a focus on the development, evaluation, and validation of digital biomarkers that help clients understand the impact of treatments on patients. Founded in 2013, Koneksa offers extensive support for remote clinical trials by merging digital health innovations with therapeutic expertise and efficient, user-friendly remote data collection to improve insights into patient health outcomes. Their advanced and validated data algorithms are tailored for immediate application in treatment development, allowing for quicker identification of signals compared to traditional techniques. The company's cloud-based Software as a Service (SaaS) platform supports real-time integration of various endpoints, granting immediate data access and facilitating informed, cost-effective decisions early in the trial stages. Furthermore, the platform's ability to collect significant remote data at higher frequencies opens doors for acquiring ecologically valid measures, which can reduce the required sample size without compromising research integrity. As Koneksa continuously enhances its methodologies and tools, it seeks to transform the approach to clinical trials, ultimately leading to more efficient and patient-centered research practices. This commitment to innovation positions Koneksa at the forefront of a rapidly evolving landscape in clinical research.

ClinCapture aims to develop software that has the potential to save lives. Their innovative technology not only lowers the expenses associated with clinical trials but also enhances the efficiency of data collection while ensuring the confidentiality of patient information. Additionally, ClinCapture serves as a comprehensive platform that supports the assessment and advancement of drugs, biologics, and medical devices, which can address a diverse range of health issues. By prioritizing both cost-effectiveness and patient privacy, ClinCapture is dedicated to improving the overall landscape of clinical research.

ClinEdge is transforming the landscape of clinical trials by providing a comprehensive suite of services tailored for Sponsors, CROs, and Sites. We utilize innovative and collaborative strategies to tackle the various challenges our clients face throughout the process. Our unwavering commitment to improving trial outcomes encompasses all phases of each study, ensuring that both Sponsors and CROs benefit from enhanced Site and Patient Access, while also delivering superior Trial Solutions to our Site partners. With over a decade of experience in the industry and a deep understanding of our clients' needs, ClinEdge is dedicated to redefining how studies are executed, ultimately leading to more efficient and effective clinical trials. Our goal is not only to innovate but also to establish new benchmarks within the clinical trial industry, fostering a culture of excellence and reliability. As we continue to grow and adapt, we remain focused on delivering exceptional value to our partners and stakeholders.

Mosio empowers research teams to enhance participant engagement, streamline communication, and gather data effectively through the widely used medium of text messaging. Our platform offers research teams the tools to interact more effectively with participants via mobile devices, integrating engaging elements and automated messaging features. WHO CAN BENEFIT? + Sponsors of clinical trials in the pharmaceutical and biotech sectors + Cancer treatment facilities and organizations focused on clinical research + Studies funded by the National Institutes of Health (NIH) + Agencies dedicated to public health + Professionals such as clinical trial managers, directors, project managers, principal investigators, and coordinators, along with all research personnel involved in participant communication. ADVANTAGES + Engaging medication reminders and alerts for compliance + Automation of the data collection process + Boost in participant engagement and adherence rates + SMS reminders for appointments to reduce no-show rates + Improved participant retention through automated check-ins, ensuring ongoing communication and support. Overall, Mosio serves as a vital tool for enhancing the efficiency of clinical research endeavors.

Suvoda stands as a prominent player in the arena of clinical trial technology, concentrating on complex, life-saving research in areas such as oncology, central nervous system disorders, and rare diseases. Founded in 2013, the organization offers a robust platform equipped with Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all designed to optimize critical patient engagements. Their cutting-edge software ensures a seamless user experience, facilitating precise randomization, effective drug supply management, and prompt data gathering. Committed to enhancing patient comprehension and reducing the burdens faced by trial sites, Suvoda's solutions are crafted to adapt to the growing intricacies of clinical research. Headquartered near Philadelphia, with additional branches throughout Europe and Asia, Suvoda has proudly aided in the execution of over 1,500 trials across more than 85 countries, demonstrating their extensive global influence and proficiency in the industry. Their unwavering focus on innovation and high standards establishes them as an essential ally in the progress of clinical research, paving the way for future breakthroughs and transformations in the field.

WCG ClinSphere introduces a revolutionary approach to executing thorough clinical trials. By utilizing artificial intelligence, this innovative platform connects sites, sponsors, CROs, and participants all within a unified cloud-based framework. It serves as a central hub for managing your trial from the very beginning to the end. The design of WCG ClinSphere rests on four core principles that enhance its overall efficiency. Our comprehensive clinical dataset underpins a federated AI learning model, promoting intelligent automation throughout the clinical trial lifecycle. Users benefit from the availability of real-time reports and insights, enabling them to stay informed and make swift decisions. The platform streamlines tasks and boosts precision through user-friendly workflows that offer assistance at each phase. Additionally, it enhances logistics, operations, and processes throughout the clinical research journey, resulting in quicker and more effective outcomes. By combining extensive data resources with sophisticated analytics, WCG ClinSphere cultivates the vital connections necessary for speeding up clinical research progress. Moreover, the platform's collaborative environment promotes ongoing innovation and improvement in trial management, ensuring that stakeholders can adapt to new challenges effectively. Overall, WCG ClinSphere represents a significant step forward in the evolution of clinical trial management.

Sarjen offers a comprehensive Clinical Trial Management System (CTMS) and Bioanalytical LIMS that brings clinical and laboratory operations together into one connected, intelligent platform. Designed to support both early-phase and late-phase studies, the solution helps sponsors, CROs, and research organizations manage the full clinical trial lifecycle with clarity and confidence. From study planning and site activation to subject tracking, financial management, and sample lifecycle oversight, every process is streamlined within a centralized environment that promotes transparency, collaboration, and control. The platform is built to drive digital transformation in clinical research by replacing fragmented systems and manual processes with automation, real-time visibility, and structured workflows. Teams can monitor study progress through intuitive dashboards, generate accurate reports with ease, and maintain regulatory compliance through standardized documentation and audit-ready data management. By unifying clinical and bioanalytical data, the system eliminates silos and enables faster, more informed decision-making across departments. As an AI-enabled solution, it enhances operational performance with predictive analytics, intelligent alerts, and automated risk identification. Features such as predictive enrollment forecasting, anomaly detection in laboratory results, smart query management, and performance analytics help reduce delays and improve overall study quality. Machine learning capabilities continuously analyze data patterns to highlight potential issues early and recommend corrective actions, allowing teams to stay proactive rather than reactive.With its flexible architecture, configurable modules, and scalable design, the platform adapts to the evolving needs of growing research organizations. By combining technology, AI, and transformation-focused innovation, it empowers clinical and laboratory teams to work smarter, accelerate development timelines.

ClinAccess™ 5.1 marks a significant advancement in our leading Clinical Data Management System, which is entirely constructed on the powerful SAS® 9 framework. This cutting-edge system enhances the efficiency of clinical data management, streamlines the analysis of clinical trials, and simplifies the preparation of electronic submissions. By allowing data entry to be performed directly into SAS® data sets, it eliminates the tedious task of transferring data from Oracle/SQL to SAS, greatly increasing your team's productivity. ClinAccess™ is designed with user-friendly features for study definitions, data entry, and management, including tools that monitor the progress and quality of ongoing clinical trials. Your data remains consistently organized within SAS® for straightforward access, whether it’s for review, analysis, or submission to regulatory bodies like the FDA. The database architecture is finely tuned to enable swift statistical analysis and reporting, ensuring users experience a significant reduction in the time and effort needed for data analysis, which can accelerate the overall time to market. Furthermore, ClinAccess™ is distinguished by its reliability, extensive auditing functionalities, and strong security protocols, making it an exceptional option for managing clinical data. With ClinAccess™, you can adeptly handle the intricacies of clinical trials while upholding data integrity and compliance standards, thereby ensuring the success of your research endeavors. This comprehensive system empowers organizations to achieve milestones with confidence in their data management processes.

At ePharmaSolutions, we are at the forefront of developing groundbreaking strategies. Although we do not consider ourselves a high-tech corporation, our core is founded on concepts that are intricately linked to technology yet not limited by it. We are transforming the drug development sector by providing solutions that optimize the processes of identifying, activating, training, and managing clinical trial sites. By reinterpreting conventional challenges through a fresh perspective, we deliver technology-enhanced solutions aimed at simplifying the complexities associated with clinical trial management. ePharmaSolutions (ePS) distinguishes itself as a leading provider of e-clinical solutions that revolutionize the processes of selecting, training, activating, and managing clinical trial sites. By introducing innovative viewpoints to persistent challenges, we develop advanced, technology-driven solutions that empower sponsors, contract research organizations, and investigator sites to efficiently tackle and streamline the complexities of clinical trial management. Our dedication to transforming these processes guarantees that we stay at the cutting edge of the industry, consistently evolving to address changing demands, ultimately fostering a more efficient and effective clinical trial landscape.

Replior stands out as an innovative company that focuses on delivering advanced software solutions tailored for clinical trials, featuring a comprehensive platform that integrates EDC, eConsent, ePRO, and Virtual Visits to optimize trial execution. Our all-encompassing system, known as Trial Online, streamlines the collection and management of data from researchers, participants, and wearable technology efficiently. It is meticulously designed to support decentralized clinical trials (DCT), providing the flexibility to accommodate site visits, remote interactions, or a blend of both. Our journey began two decades ago when we were tasked with developing an online CRF service for a prominent pharmaceutical company, which marked our evolution from an IT operations provider into a specialized software developer focused on clinical data collection. Over time, we have broadened our offerings to provide a full range of data collection services, while our IT operations are adeptly overseen by our highly skilled sister company, Complior. As we forge ahead, our unwavering commitment to innovating and improving clinical trial processes remains central to our purpose, driving us to continually enhance user experience and data integrity in the trials we support.

BSI CTMS stands out with its cutting-edge interface and smart data visualization features. Our software for managing clinical trials goes beyond mere aesthetics, providing essential tools that support pharmaceutical, biotech, and diagnostics sponsors, as well as contract research organizations (CROs) and academic sites (SMOs), in efficiently overseeing their clinical trials. The ongoing development of BSI CTMS is driven by market demands and involves collaboration with industry stakeholders. What sets BSI CTMS apart is its comprehensive offering that combines CTMS, eTMF, and Study Startup capabilities into a single integrated platform. Unlike traditional standalone solutions like Excel, which fall short in functionality, our software provides a cohesive experience for users. This integration not only streamlines workflows but also enhances overall productivity in the clinical trial process.

Data MATRIX provides an all-encompassing SaaS platform tailored specifically for clinical trial management. Established in 2009, the Data MATRIX team has focused on the intricate processing and analysis of clinical data, producing documentation that adheres to the regulations set forth by the Russian Ministry of Health, FDA, and EMA. Our innovative software simplifies the clinical trial workflow, enabling users to effectively oversee and monitor their progress through an online interface. Prior to the initiation of any project, we ensure to thoroughly adjust and validate our software, taking into account every detail necessary for peak performance. With a successful history of completing 180 projects for various pharmaceutical companies, biotech enterprises, and contract research organizations, our solutions have contributed to 6 of the top 10 Big Pharma firms achieving a notable 15% decrease in research and development costs. The commitment of our dedicated team extends beyond projects as they are actively engaged with professional networks that link clinical data professionals such as CDISC, ACDM, SCDM, biostatisticians like ISBC, and medical writers affiliated with EMWA and AMWA. By consistently refining and advancing our offerings, we strive to foster innovation within the clinical research sector, ensuring that our solutions remain at the forefront of industry needs. This commitment to progress not only supports our clients but also enhances the overall landscape of clinical trials globally.

In the past few years, the Life Sciences industry has faced fines and settlements totaling almost $15 billion due to compliance issues, highlighting the critical need for companies to adhere to best practices in pharmaceuticals, medical devices, and biotechnology. Furthermore, the management of clinical trials significantly impacts the duration, scope, and financial investments necessary for the advancement of drugs and medical devices. By leveraging OpenText™ Clinical Trial Quality Management System (ctQMS), organizations can ensure compliance, reduce record-keeping costs, and promote collaboration to implement best practices throughout the clinical trial process. This strategic methodology not only boosts operational efficiency but also plays a vital role in the successful development of products. Ultimately, embracing such advanced systems can lead to more innovative solutions in the healthcare landscape.

Judi represents a cutting-edge cloud platform tailored for collaboration in clinical trials, focused on improving, safeguarding, and simplifying complex workflows among sponsors, CROs, trial sites, and various collaborators. This platform integrates an extensive range of trial functionalities, including endpoint and event adjudication, central eligibility assessments, data safety monitoring, remote oversight, medical imaging, site/user qualification, and customizable workflows via Judi Flex. By eliminating outdated manual methods, spreadsheets, untracked emails, and isolated file-sharing practices, Judi fosters a unified and compliant environment where all documents, communications, images, queries, and decisions are managed through secure and accountable channels. Among its impressive features are role-based access controls, comprehensive audit trails, instantaneous messaging, streamlined query management, personalized dashboards, adaptable worklists, versatile document submission and review systems, eCRFs equipped with edit checks, and sophisticated reporting mechanisms that collectively enhance the speed and accuracy of trial data collection, review, and reporting processes. Additionally, the platform’s holistic strategy enables all participants to work together effortlessly, ultimately resulting in enhanced outcomes and expedited trial timelines. This innovative approach not only supports regulatory compliance but also helps in maintaining high-quality data throughout the trial lifecycle.

Deep 6 AI transforms the patient enrollment landscape for clinical trials by innovatively altering the methods researchers use to locate appropriate candidates. Utilizing cutting-edge artificial intelligence and natural language processing, DEEP 6 AI adeptly navigates through both structured and unstructured patient data, allowing for the rapid identification of a broader range of well-suited trial participants in just minutes, a stark contrast to the months traditionally required. The platform works in conjunction with prominent health systems, pharmaceutical firms, and contract research organizations, establishing itself as a pivotal element of the clinical research framework and significantly accelerating patient access to trials. Beyond just speeding up enrollment, Deep 6 AI’s groundbreaking software analyzes structured data, such as ICD-10 codes, alongside unstructured clinical information like physician notes, pathology reports, and surgical documents, which can often be challenging to sift through. This thorough examination guarantees that researchers can swiftly locate candidates who fulfill specific requirements, thereby facilitating a quicker rollout of innovative treatments for those in need. Consequently, the integration of this technology not only enhances the efficiency of trial processes but also holds the potential to transform patient care by ensuring timely access to life-saving therapies.

Accelerating the development of essential drugs while guaranteeing equitable access to high-quality cancer therapies and research for patients globally is paramount. Our innovative technology is revolutionizing patient access to state-of-the-art medications and participation in clinical trials. FICS represents a pioneering software solution that streamlines the collection of regulatory-compliant data during patient treatment. By unifying disparate and previously disconnected applications into a cohesive and efficient platform, FICS enhances the speed and quality of clinical trials, which significantly improves patient outcomes. This transformative approach not only simplifies the trial process but also fosters better collaboration among researchers and healthcare providers.

Mahalo Health is a comprehensive digital health platform designed to accelerate the development of patient-centered digital health solutions and clinical trials. It offers an array of prebuilt modules that enable the rapid deployment of customizable white-label applications tailored to specific therapeutic areas. The platform is equipped with advanced data capabilities, which include a predictive health engine for anticipating diseases and diagnoses, a behavior modification engine that promotes healthy patient habits, and a notification system that guarantees prompt communication via push notifications, SMS, or emails. Mahalo Health is dedicated to upholding rigorous security and compliance standards, adhering to regulations like HIPAA, GCP, ISO27001, and GDPR. Its diverse service offerings span various therapeutic domains, such as diabetes management, cognitive health, cardiovascular care, musculoskeletal issues, mental well-being, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Furthermore, Mahalo Health not only enhances patient engagement but also improves health outcomes by equipping healthcare providers with innovative digital tools and solutions that adapt to the evolving needs of their patients. This commitment to innovation ensures that healthcare delivery is both efficient and personalized.

Clin'form is a robust and flexible electronic Clinical Outcome Assessment (eCOA) platform designed to enhance the efficiency of clinical trials for both participants and research facilities, while also improving data accuracy and expediting processes for research teams. Its adaptability allows it to be utilized across a wide array of protocols and demographics, making it ideal for any questionnaire type, including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries, catering to a diverse demographic from children to seniors. The platform is engineered to accommodate varying population sizes, effectively managing studies that involve small cohorts as well as those with more than 10,000 participants across multiple global locations. Clin'form seamlessly integrates with other clinical systems to create an efficient workflow, supporting a range of data collection methods—including dedicated tablets, smartphones, patients' personal devices, web access via any browser, and in-person interviews. A standout feature is the integrated tele-visit option, which provides flexibility in response to unforeseen changes, along with patient engagement tools that are designed to foster high compliance rates. Furthermore, the intuitive interface of Clin'form ensures that both researchers and participants can navigate the platform with ease, thereby enhancing the overall clinical trial experience and effectiveness. Overall, Clin'form not only streamlines the data collection process but also places a strong emphasis on user experience, making it a valuable asset in clinical research.

cubeCTMS serves as a comprehensive clinical trial management platform that ensures thorough supervision of trials, which includes monitoring study sites and investigators, handling participant enrollment and visit schedules, and managing budgets and contract workflows, along with milestone reporting and document oversight. By consolidating study operations and automating key processes, it enables sponsors, CROs, and research teams to track progress in real time, coordinate activities across multiple studies, improve communication with study sites, and mitigate risks. The platform features integrated dashboards, alerts, and audit-ready documentation to maintain compliance with regulatory requirements, including readiness for FDA 21 CFR Part 11, thus empowering stakeholders to manage trial schedules, resources, and overall performance from a unified interface. Furthermore, cubeCTMS effortlessly integrates with other modules of CRScube, such as EDC, eTMF, and pharmacy/RTSM, forming a harmonious ecosystem that reduces redundancy, enhances data flow, and accommodates flexible workflows during amendments or extensive implementations. This integration not only streamlines various processes but also significantly boosts the overall effectiveness of clinical trials, ultimately proving to be an essential asset for research teams dedicated to advancing medical knowledge. With its user-friendly design and robust features, cubeCTMS sets a new standard in clinical trial management solutions.

Sano Genetics offers an all-encompassing platform tailored for precision medicine and clinical trial initiatives, seamlessly merging elements such as patient recruitment, genetic analysis, informed consent, and continuous participant interaction to significantly optimize research workflows. This platform enables the development of customized protocols and the assembly of ethical submission materials, while also implementing digital prescreening and consent processes, as well as recruitment support through targeted online marketing, collaborations, and advocacy initiatives, thereby facilitating connections between sponsors, contract research organizations, and specific patient demographics that are frequently underserved in various areas. In addition, Sano provides accessible, non-invasive saliva-based DNA testing kits that present a cost-effective alternative to conventional blood draws, alongside logistical support for the collection and processing of samples. Their offerings extend to reliable genetic and biomarker evaluations from accredited labs, bioinformatics solutions, and the communication of results, enhanced by genetic counseling when appropriate, which collectively ensure a comprehensive approach to patient management and study integrity. Furthermore, by harnessing advanced technology and fostering community involvement, Sano Genetics is set to revolutionize the field of clinical trials and personalized healthcare, paving the way for more inclusive and efficient medical research. This innovative approach not only benefits sponsors but also prioritizes the needs of diverse patient populations.

Dacima Clinical Suite stands out as a cutting-edge web-based platform that integrates electronic data capture (EDC), clinical data management software (CDMS), and clinical trial management tools into a single cohesive solution. Tailored for a variety of applications, it effectively supports clinical trials, epidemiological research, web randomization, electronic patient-reported outcomes (ePRO), surveys, and patient registries. The suite features three essential modules: the Manager (Administrator), the Designer Module, and the Data Entry Module, each playing a vital role in streamlining the research process. This comprehensive approach ensures that users have all necessary tools at their fingertips for efficient data management and analysis.

ClinOne is an all-inclusive platform designed to improve the connectivity and empowerment of participants, caregivers, and clinical trial sites by delivering critical tools that promote trial awareness, manage consent, and enhance participant engagement and retention, all underpinned by comprehensive data analytics and standardized interoperability. One of its standout features, Site Hub, serves as a centralized location for trial sites to find essential information, such as participant eligibility criteria, available resources, and a unified systems landing page that includes single sign-on capabilities and options for community engagement. The Connect module adds further depth to the platform with components like the Sponsor & Monitor Hub, initiatives to raise trial awareness, a network for healthcare providers, streamlined site selection, and data that emphasizes diversity, equity, and inclusion. In parallel, the Inform module is dedicated to simplifying consent management and education, utilizing eConsent with eSignature capabilities, while also providing insights through data, facilitating tele-visits, and creating opportunities for community collaboration. Furthermore, the Empower module significantly enriches the clinical trial experience by offering transportation management services, monitoring medication adherence, and establishing a dedicated portal specifically for caregivers and care partners, thereby ensuring that participants receive comprehensive support throughout their clinical trial experience. Ultimately, ClinOne is committed to transforming the landscape of clinical trials by leveraging technology to create a more engaging and supportive environment for all stakeholders involved.

The Clinical Trial Search utilizes advanced artificial intelligence to simplify complex trial data, which significantly boosts both participant involvement and enrollment rates. Key benefits include: Enhanced Engagement: Offering clear and concise information that aids potential participants in grasping the details more effectively. Wider Accessibility: Reaching a diverse array of motivated individuals eager to explore clinical trial opportunities. Listing trials on Clinical Trial Search is completely free, and we also offer referral bonuses that range from $300 to $5,000 based on the trial's intricacy. Furthermore, our platform guarantees that trials are easily accessible to interested individuals, thereby improving overall recruitment initiatives and ensuring that more people can take part in vital research.

Inspirata is an AI-powered oncology platform designed to help healthcare organizations optimize their cancer service lines end to end. It enables accurate, complete, and timely cancer reporting to meet state and federal compliance requirements. The platform uses advanced AI and NLP to automate casefinding, tumor classification, and data abstraction in real time. Inspirata unlocks idle clinical data by structuring pathology, radiology, and clinical reports for research and discovery. Built-in workflows improve operational efficiency, reduce staff burden, and enhance care coordination. Real-time trial matching helps increase clinical trial accrual and ensures unbiased access for eligible patients. Patient navigation capabilities support seamless care from diagnosis through treatment and survivorship. Inspirata integrates with EHRs, registries, and research systems using industry standards. Its solutions are continuously updated to reflect best practices and evolving oncology reporting requirements. Used by academic medical centers and cancer programs worldwide, Inspirata improves both clinical outcomes and financial performance. The platform is supported by decades of oncology-focused expertise. Overall, Inspirata helps cancer centers strengthen their reputation, improve quality of care, and accelerate innovation.

ArcheMedX offers a solution designed for pharmaceutical and biotech trusts to enhance the effectiveness of their trial teams, streamline decision-making processes, and minimize delays in studies. By identifying the most capable sites and teams for conducting trials, organizations can sidestep common pitfalls that lead to study postponements. This approach not only cuts down on the time and expenses associated with problem resolution, particularly in the early phases of a trial, but also ensures that selected sites have a thorough understanding of patient eligibility criteria. Consequently, you can trust that they are better positioned to enroll suitable patients more efficiently, achieve enrollment goals, and reduce screen failure rates. Additionally, the trial team’s deep familiarity with the study protocol and its specific objectives fosters a comprehensive understanding of the project. This proactive strategy allows for the anticipation of potential risks, enabling teams to mitigate them effectively and ultimately resulting in fewer deviations throughout the trial process. Overall, this systematic preparation leads to a smoother and more successful trial execution.

Advancing artificial intelligence to eliminate the necessity for trial and error in healthcare, our digital twins enable rapid and reliable clinical trials. We prioritize research in fields such as neuroscience, immunology, and metabolic disorders, among others. TwinRCTs accelerate full enrollment by requiring fewer participants to achieve the same statistical power as traditional trial methods. This innovative strategy drastically cuts down on the time needed for late-stage study enrollment. Furthermore, TwinRCTs improve the detection of treatment effects in early-stage research by increasing statistical power without needing more participants. They allow researchers to make well-informed decisions based on initial findings and assist in attracting additional participants to clinical trials. By utilizing smaller control groups, TwinRCTs also enhance the likelihood of participants receiving the experimental treatment. Our dedication to ensuring that clinical trials with digital twins achieve regulatory approval remains steadfast. Unlearn is leading the charge in revolutionizing the healthcare industry through the pioneering use of artificial intelligence, crafting and applying cutting-edge generative models that utilize extensive datasets gathered from prior patient studies. This shift in methodology not only optimizes research efficiency but also significantly improves the effectiveness of clinical trials. The future of medicine is being reshaped as we continue to refine these innovative approaches.

Medilake stands out as the top-tier solution for managing both clinical and non-clinical trial data with efficiency and precision. We are excited to present Medilake, an innovative and adaptable platform designed to facilitate the effective handling of trial data across various domains. In a time when data is crucial for advancing healthcare and research, Medilake is the ideal choice for simplifying and enhancing data management practices. What makes Medilake the preferred option for managing trial data, both clinical and non-clinical? Centralized Data Hub - Enhanced collaboration - Robust Data Integrity & Security Sophisticated Analytics - Along with Customization and Scalability to meet diverse needs.

Enhance the efficiency of your clinical studies with Clinvigilant, your global provider of budget-friendly eClinical tools tailored for CROs, Pharma, Biotech, Nutraceuticals, and academic institutions throughout both clinical and post-marketing phases. Our clients consistently choose to partner with us due to our: ♦ Rapid EDC implementation (under 4 weeks). ♦ Cost-effective solutions. ♦ Integration capabilities with third-party and legacy systems. Our cloud-based platform, hosted on Microsoft Azure, adheres to HIPAA, ICH-GCP, GDPR, and 21 CFR part 11 regulations and has successfully undergone audits by the FDA, EMA, and MHRA. The Clinvigilant eClinical suite encompasses a variety of tools, including EDC, CTMS, eCRF, eTMF, eSource, IWRS, ePRO, eConsent, and eCOA. You can select the specific tools you require, and we will seamlessly integrate them into your existing software framework. Each interaction and data exchange generates detailed Audit Trails, ensuring real-time visibility of compliant data across all relevant roles. Our offerings are modular, highly customizable, and accessible via web, iPad, and mobile applications for both Android and iOS platforms. Additionally, we support the use of Patient's Own Devices (BYOD) and can interface with various devices and wearables for enhanced data collection. With Clinvigilant, you can count on a comprehensive solutions provider to streamline your clinical trial processes effectively and efficiently. Your success in clinical research begins here.

Phoenix CTMS is an advanced, integrated web application that merges the essential tools of clinical research—Patient Recruitment System (PRS), Clinical Trial Management System (CTMS), and Clinical Data Management System (CDMS)—into a unified, modular platform available for free under an open source license (LGPL 2.1). It is tailored to support the operational workflows and regulatory compliance requirements of academic research centers, contract research organizations (CROs), and hospitals conducting clinical trials across all phases. Developed through years of collaboration with the Medical University of Graz, Phoenix CTMS offers a secure and private encrypted subject registry that protects personally identifiable information (PII) and complies with stringent EU-GDPR standards. The system provides a powerful electronic data capture (EDC) package with unlimited JavaScript scripting on both server and client sides, supporting complex and large electronic case report forms (eCRFs) not easily handled by other solutions. Phoenix CTMS facilitates the management of multiple concurrent clinical trials while efficiently organizing site staff and resources. The platform enables users to formulate complex ad-hoc database queries and supports set operations to identify suitable subject candidates. Its turnkey design allows institutions to deploy the system quickly without integrating several separate applications, enhancing efficiency and data security. This system is ideal for organizations needing a serious open source alternative for clinical data management and trial execution. Phoenix CTMS also helps ensure compliance with ICH GCP (Good Clinical Practice) guidelines, providing a reliable and comprehensive research management tool. Overall, Phoenix CTMS combines flexibility, security, and comprehensive functionality to meet the evolving needs of clinical research professionals.

Altis Labs has introduced Nota, a groundbreaking platform aimed at improving the efficiency of therapeutic research and development in the clinical field. By leveraging artificial intelligence, Nota assesses imaging data to forecast patient outcomes, enabling sponsors to better concentrate on their most viable therapies. This cutting-edge tool equips researchers with the ability to utilize imaging data from clinical trials, access predictive biomarkers, and accelerate research initiatives on a broader scale. With Altis' cloud-based software that employs deep learning techniques, biopharma companies can achieve comprehensive outcome predictions at the levels of individual images, patients, and entire cohorts, thereby enhancing the design of clinical trials and boosting confidence in predicting clinical endpoints. The insights provided by Nota hold the potential to significantly shorten development timelines, reduce drug development costs, and increase the likelihood of success in clinical trials across diverse therapeutic areas. Furthermore, Nota signifies a major leap forward in the fusion of technology with clinical research, ultimately paving the way for more streamlined and effective drug development methodologies. This innovation not only promises to transform the landscape of clinical trials but also aims to improve patient outcomes in the long run.